Clinical trials in rare diseases present unique challenges unseen in trials for more common conditions. Cross-border enrollment can be key to enrolling and retaining the required number of participants in a rare disease clinical trial. However this creates complex patient logistics and a regulatory maze that must be appropriately navigated. Understanding these considerations is critical to timely and successful study completion.
Certain challenges within the drug development landscape merit a dedicatedtask force of experts and capabilities. That’s why we built our collection…
We work hand-in-hand with our sponsors to develop strategic, flexible approaches that leverage Clinical Informatics, state-of-the-art technologies,…
Our collaborative, cross-functional team develops tailored, cost-effective services to meet the unique needs of biosimilars clinical development.